← All indications
Tumor Suppressor Proteins
Proteins that are normally involved in holding cellular growth in check. Deficiencies or abnormalities in these proteins may lead to unregulated cell growth and tumor development.
Subtype terms (28)
More specific conditions that are subtypes of Tumor Suppressor Proteins in the MeSH hierarchy.
- Adenomatous Polyposis Coli Protein
- BRCA1 Protein
67 drugs (47 approved, 20 experimental)
- BRCA2 Protein
1 drug approved
- Cyclin-Dependent Kinase Inhibitor Proteins
- Cystatin M
- DCC Receptor
- Deubiquitinating Enzyme CYLD
- Fanconi Anemia Complementation Group N Protein
- Inhibitor of Growth Protein 1
- Kangai-1 Protein
- Kisspeptins
- Neurofibromin 1
8 drugs (5 approved, 3 experimental)
- Neurofibromin 2
- Patched Receptors
- Promyelocytic Leukemia Protein
- PTEN Phosphohydrolase
3 drugs (2 approved, 1 experimental)
- Retinoblastoma-Like Protein p107
- Retinoblastoma-Like Protein p130
- Retinoblastoma Protein
- Smad4 Protein
- Tuberous Sclerosis Complex 1 Protein
- Tuberous Sclerosis Complex 2 Protein
- Tumor Protein p73
- Tumor Suppressor Protein p14ARF
- Tumor Suppressor Protein p53
33 drugs (28 approved, 5 experimental)
- Von Hippel-Lindau Tumor Suppressor Protein
- WT1 Proteins
3 drugs (2 approved, 1 experimental)
- WW Domain-Containing Oxidoreductase